Clinical trials
Eye Diseases clinical trials
Below are recruiting eye diseases clinical trials, each written for real people, not researchers. We’re tracking 181 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05851287Recruiting
Eye and health check study for adults 65 and older
This study enrolls people age 65+ to get regular eye and general health checkups. It may help doctors understand what eye problems are developing and how to catch them earlier.
Guangzhou, GuangdongAges 65 years+ - NCT06177639Recruiting
A new eye camera designed for children and babies
This trial is testing a new, more comfortable eye camera designed for children and babies. It takes wide-angle pictures of the back of the eye (retina) to see if it works better than current cameras. You or your child can join even if you have healthy eyes or an eye condition.
Durham, North CarolinaAges 4 weeks+ - NCT06643338Recruiting
Testing AI to spot eye nerve conditions in the ER
This trial is testing a new computer system that uses photographs of the back of your eye (color fundus photos) to help doctors quickly identify certain nerve or vision problems in the emergency room. If you come to the specific hospital and meet the basic requirements, this study will take pictures of your eyes to see if the AI can spot conditions more accurately.
ParisAges 18 years+ - NCT06655441RecruitingPhase 4
Trehalose eye drops for dry eye disease
This study tests if a special sugar-based eye drop called trehalose can improve the protective layer of the eye in people with moderate to severe dry eye. It might help strengthen the cornea and reduce discomfort.
Fullerton, CaliforniaAges 18 years+ - NCT06717048Recruiting
Finding the best red light therapy for myopia in children
This study tests whether a special red light therapy can help slow down the progression of nearsightedness in children. It compares different amounts of light and how often it is used to find the best way to keep myopia from getting worse.
Shanghai, Shanghai MunicipalityAges 8–10 - NCT06879834Recruiting
AI software for diabetic eye screening
This study tests an AI platform that checks for diabetic retinopathy, a common eye problem in people with diabetes. It aims to see if the AI can spot signs of damage early, so you can get treatment sooner.
OdesaAges 18–90 - NCT06943599Recruiting
Improving Eye Care After Screening
This study looks at better ways to help people get follow-up eye care after a screening. If you were in the VIEW II study and were referred to an eye hospital, this trial may offer strategies to support you in getting that care.
San Francisco, CaliforniaAges 60 years+ - NCT06989918RecruitingPhase 3
Study of MHB018A for active thyroid eye disease
This trial tests a new medicine called MHB018A for people with active, moderate to severe thyroid eye disease. It aims to see if the drug can reduce eye symptoms like bulging and inflammation.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06995911Recruiting
Virtual reading device trial for pre-myopic children
This study tests if a special virtual reading device can slow or prevent nearsightedness (myopia) in children who are starting to show signs of it. It's for kids ages 6 to 12 with mild farsightedness or beginning nearsightedness and at least one parent who is nearsighted.
ShanghaiAges 6–12 - NCT07118241RecruitingPhase 2
Testing a new eye drop for Sjögren's dry eye
This trial tests a new eye drop made from a natural protein (rhPRG4) to see if it safely and effectively relieves dry eye symptoms in people with Sjögren's syndrome. You'll be randomly assigned to receive the study drop or a placebo (inactive) drop for several weeks.
Sydney, New South WalesAges 18–80 - NCT07155057Recruiting
Dry eye gel for cataract surgery patients
This study tests a gel placed into the tear drain to treat dry eye in people who are also getting cataract surgery. You may be able to join if you have dry eye and are having cataract surgery.
Sioux Falls, South DakotaAges 22 years+ - NCT07228793Recruiting
A study tracking EYS-related retinitis pigmentosa over time
This study follows people with retinitis pigmentosa caused by changes in the EYS gene over 4 years. It collects data on how the disease progresses and does not test any new treatments.
MoscowAges 14–100 - NCT07308639Recruiting
Eye disease health data study in Germany
This study looks at health records in Germany to understand how many people have certain eye conditions like age-related macular degeneration, diabetic macular edema, or retinal vein occlusion. It also tests new ways to use this information for research.
LeverkusenAges 18 years+ - NCT07312214Recruiting
Red light therapy for slowing vision loss in severe nearsightedness
This trial tests if daily low-level red light can protect the back of the eye in people with severe nearsightedness. It aims to slow damage that leads to vision loss.
ShanghaiAges 18–55 - NCT02485847Recruiting
Join an eye health research registry
This trial is a research registry that collects information from people who are getting eye care. It helps researchers better understand eye disease and outcomes over time, which may improve future care.
San Francisco, CaliforniaAges 6 months+ - NCT07514039Enrolling by invitation
Special Myopia Glasses for Children and Teens
This study tests new glasses with special microscopic patterns designed to slow down myopia (nearsightedness) in children and teenagers. Researchers want to see if wearing these glasses can help prevent myopia from getting worse.
ShanghaiAges 6–14 - NCT07284147Enrolling by invitation
3D designed defocus lenses for slowing myopia in children
This trial tests special glasses with 3D defocus lenses to slow down the progression of myopia (nearsightedness) in children and teens. It aims to see if these lenses are more effective than standard glasses at preventing vision from getting worse.
ShanghaiAges 6–14 - NCT06927544Enrolling by invitation
Gas bubble treatment for large macular holes
This trial tests a gas bubble procedure to repair large macular holes in people aged 50 and older. It aims to improve vision by closing the hole without traditional surgery.
OdesaAges 50–90 - NCT06232616Enrolling by invitation
Eye surgery with steroid implant for membrane-related swelling
This study tests combining vitrectomy (surgery to remove the membrane from the retina) with a dexamethasone implant (a tiny steroid that is placed inside the eye to reduce swelling) for people with a specific type of eye membrane and fluid buildup in the center of the retina.
Shanghai, Shanghai MunicipalityAges 40 years+ - NCT06221592Enrolling by invitation
New glasses for slowing myopia in children
This study is testing the safety and comfort of new glasses with special lenses designed to slow down nearsightedness in children. It compares differences between the new lenses and regular lenses, and the child will wear them for a period of time to see how they feel and if there are any concerns.
Shanghai, Shanghai MunicipalityAges 6–14 - NCT06755190Recruiting
AI help for eye disease decisions
This trial uses artificial intelligence to help doctors make better decisions about eye disease. It analyzes your medical records and images to see how AI can improve care and track disease.
Zhuhai, GuangdongAges Any age - NCT00286637Recruiting
New tests to diagnose glaucoma and related eye problems
This study tests new ways to diagnose glaucoma (and sometimes related eye conditions) using eye exams and measurements. It may help improve how doctors detect glaucoma earlier and more accurately.
Philadelphia, PennsylvaniaAges 18 years+ - NCT01403402Recruiting
Study of congenital muscle disease patients and their families
This trial collects health information from patients with certain inherited (genetic) muscle diseases and from their families. It may help researchers better understand the disease and improve care by learning what symptoms and treatments patients experience over time.
Lakewood, CaliforniaAges Any age - NCT01145196Recruiting
Study drug eye damage and genes in Plaquenil users
This study looks at how Plaquenil (hydroxychloroquine) can harm the retina (the eye’s light-sensing layer) and whether genetics affect who gets affected. You may help by sharing medical details and providing an eye-related blood sample so researchers can compare gene patterns to eye findings.
Bethesda, MarylandAges 18–120
Hear when a new Eye Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for eye diseases?
- Yes. Clin2 currently lists 181 recruiting eye diseases studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a eye diseases trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a eye diseases trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.